Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed

Aliment Pharmacol Ther. 2023 Oct;58(8):838-839. doi: 10.1111/apt.17678.

Authors

Bridgette Andrew¹, Annie Zhou¹, Steven Trinh¹, Ashish Srinivasan^{1

2}, Abhinav Vasudevan^{1

2}

Affiliations

¹ Department of Gastroenterology, Eastern Health, Melbourne, Australia.
² Monash University, Melbourne, Australia.

PMID: 37768293
DOI: 10.1111/apt.17678

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents* / adverse effects
Dysbiosis
Humans
Inflammatory Bowel Diseases* / drug therapy

Substances

Anti-Bacterial Agents